Navigation path

A Snapshot of the Biosimilar Market Dynamics_IQVIA Report 2019
Market Dynamics from a DG COMP Perspective
Tools to Optimize Biosimilars Benefits from a Societal Perspective_HU Semmelweis University
Biosimilars in Slovakia_A Slovakian Union Health Insurance Fund Perspective
Update on Biosimilars in Germany_A German Physicians Association (KVWL) Perspective
Promoting the Use of Biosimilars in France_A FR Ministry of Solidarity & Health Perspective
How to Improve Early Access to Biosimilars_A Pharmacist's Perspective
Sustainable Procurement of Medicines_A Perspective from DG GROW
Biosimilars in the EU_A paradigm in Regulatory Science_A European Medicines Agency Perspective
Ways to Foster Biosimilars Access to Patients_A Clinician Perspective
How to Improve Early Access to Biosimilars_A Patients Organisation Perspective
How to Improve Early Access to Biosimilars_A European Specialist Nurses Organisation Perspective
Danish Experience with Biosimilars_A Danish Medicines Agency Perspective
Biosimilars in Hungary_A Hungarian Institute of Health Insurance Fund Perspective
List of organisations which attended the conference
Results per page: 5 10 15 20 25 | Page 1 out of 4

Additional tools